Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Sosei raises 11.2B Yen in IPO

Drug development and reprofiling company Sosei (Tokyo, Japan) is raising 11.2 billion Yen ($104 million) in an IPO

Read the full 186 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE